News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,774 Results
Type
Article (14200)
Company Profile (282)
Press Release (252292)
Section
Business (79503)
Career Advice (153)
Deals (13224)
Drug Delivery (35)
Drug Development (50446)
Employer Resources (31)
FDA (5716)
Job Trends (5127)
News (144387)
Policy (10029)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (911)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21640)
ALS (61)
Alzheimer's disease (836)
Antibody-drug conjugate (ADC) (88)
Approvals (5734)
Artificial intelligence (112)
Autoimmune disease (13)
Automation (5)
Bankruptcy (104)
Best Places to Work (4560)
BIOSECURE Act (5)
Biosimilars (40)
Biotechnology (232)
Bladder cancer (45)
Brain cancer (20)
Breast cancer (142)
Cancer (1318)
Cardiovascular disease (112)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (308)
Cervical cancer (8)
Clinical research (40918)
Collaboration (500)
Compensation (228)
Complete response letters (13)
COVID-19 (1034)
CRISPR (37)
C-suite (146)
Cystic fibrosis (76)
Data (1385)
Denatured (11)
Depression (29)
Diabetes (126)
Diagnostics (1294)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (79)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (83)
Earnings (29689)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48186)
Executive appointments (410)
FDA (6348)
Featured Employer (31)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (471)
Gene editing (90)
Generative AI (9)
Gene therapy (235)
GLP-1 (358)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6590)
Huntington's disease (21)
IgA nephropathy (22)
Immunology and inflammation (80)
Indications (18)
Infectious disease (1096)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (58)
Interviews (17)
IPO (7263)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (203)
Leadership (2)
Legal (1386)
Liver cancer (30)
Lung cancer (187)
Lymphoma (84)
Machine learning (1)
Management (7)
Manufacturing (116)
MASH (49)
Medical device (2589)
Medtech (2590)
Mergers & acquisitions (6259)
Metabolic disorders (366)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (61)
Neuropsychiatric disorders (23)
Neuroscience (1215)
NextGen: Class of 2025 (2017)
Non-profit (852)
Northern California (1575)
Now hiring (21)
Obesity (186)
Opinion (100)
Ovarian cancer (60)
Pain (41)
Pancreatic cancer (51)
Parkinson's disease (111)
Partnered (8)
Patents (112)
Patient recruitment (68)
Peanut (35)
People (25521)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14446)
Phase II (19036)
Phase III (12040)
Pipeline (744)
Podcasts (47)
Policy (38)
Postmarket research (852)
Preclinical (6067)
Press Release (30)
Prostate cancer (55)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (277)
Real estate (1415)
Recruiting (12)
Regulatory (8577)
Reports (15)
Research institute (937)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (56)
Series A (92)
Series B (60)
Service/supplier (1)
Sickle cell disease (39)
Southern California (1394)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1971)
State (1)
Stomach cancer (4)
Supply chain (18)
Tariffs (3)
The Weekly (35)
United States (12279)
Vaccines (205)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (61)
Last 7 days (406)
Last 30 days (1604)
Last 365 days (19948)
2025 (4950)
2024 (20552)
2023 (22415)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10393)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17226)
Australia (2921)
California (3571)
Canada (1059)
China (326)
Colorado (138)
Connecticut (143)
Delaware (88)
Europe (37050)
Florida (423)
Georgia (110)
Idaho (16)
Illinois (214)
India (9)
Indiana (87)
Iowa (1)
Japan (71)
Kansas (60)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (446)
Massachusetts (2820)
Michigan (69)
Minnesota (138)
Mississippi (1)
Missouri (23)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (893)
New Mexico (12)
New York (968)
North Carolina (525)
North Dakota (4)
Northern California (1575)
Ohio (108)
Oklahoma (9)
Oregon (21)
Pennsylvania (680)
Puerto Rico (3)
Rhode Island (15)
South America (208)
South Carolina (4)
Southern California (1394)
Tennessee (25)
Texas (412)
Utah (48)
Virginia (70)
Washington D.C. (28)
Washington State (324)
Wisconsin (13)
266,774 Results for "aldeyra therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aldeyra Therapeutics to Participate in the 2025 Leerink Partners Global Healthcare Conference
March 10, 2025
·
1 min read
Regulatory
FDA Action Alert: Amgen, Aldeyra and Argenx
In the coming two weeks, the FDA is expected to announce three big decisions, including one for a dry eye disease therapy.
March 31, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
April 3, 2025
·
10 min read
Press Releases
Aldeyra Therapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
1 min read
Genetown
Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference
Aldeyra Therapeutics, Inc. today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference.
May 29, 2024
·
1 min read
Press Releases
Aldeyra Therapeutics to Participate in the Citi 2024 Global Healthcare Conference
December 2, 2024
·
1 min read
Genetown
Aldeyra Therapeutics to Host Investor Roundtable Q&A
Aldeyra Therapeutics, Inc., a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, announced that the company will host an Investor Roundtable Q&A via webcast on Thursday, June 20, 2024 at 8:00 a.m. ET.
June 12, 2024
·
1 min read
Press Releases
Aldeyra Therapeutics to Participate in the Jefferies London Healthcare Conference
November 14, 2024
·
1 min read
Drug Development
Aldeyra Therapeutics Completes Enrollment in Phase 3 Clinical Trial of Reproxalap in Dry Eye Disease
Aldeyra Therapeutics, Inc. announced the completion of enrollment in a Phase 3 dry eye chamber clinical trial of topical ocular 0.25% reproxalap, an investigational RASP modulator, for the treatment of dry eye disease.
June 13, 2024
·
8 min read
Genetown
Aldeyra Therapeutics Announces Advancement of New RASP Modulators and Recent Preclinical Data in Obesity at 2024 Investor Roundtable
Aldeyra Therapeutics, Inc. today announced advancement of new RASP modulators and recent preclinical data in obesity in conjunction with an Investor Roundtable scheduled to begin at 8:00 a.m. ET today.
June 20, 2024
·
8 min read
1 of 26,678
Next
